KW-2246 (fentanyl citrate)

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

CancerPainPain, Cancer

Phase 2

Clinical Study of KW-2246 in Patients With Cancer Pain

CompletedNCT00355628

Kyowa Kirin Co., Ltd.Cancer, Pain

Start: 2006-07-31Target: 40Updated: 2012-08-31

Phase 3

A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

CompletedNCT00684632

Kyowa Kirin Co., Ltd.Pain, Cancer

Start: 2008-03-31End: 2009-04-30Updated: 2020-08-28

A Phase III Clinical Study of KW-2246

CompletedNCT00683995

Kyowa Kirin Co., Ltd.Pain, Cancer

Start: 2008-03-31End: 2011-10-31Updated: 2020-08-28

Related Papers

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.

2014-11-068 citations